Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paraneoplastic neurological syndromes.

Ian Sutton1

  • 1Department of Medicine, University of Sydney, Australia. iansutton@hotmail.com

Current Opinion in Neurology
|November 26, 2002
PubMed
Summary

Recent advances in paraneoplastic neurological syndromes focus on cellular immunity and improved diagnostics. Effective tumor treatment can stabilize neurological symptoms, offering hope for patients with these rare autoimmune disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.

Brain : a journal of neurology·2025
Same author

Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry·2024
Same author

Neutropaenia complications from Ocrelizumab and Rituximab treatment.

Multiple sclerosis and related disorders·2023
Same author

Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant.

Cytotherapy·2023
Same author

Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis.

Clinical immunology (Orlando, Fla.)·2023
Same author

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

JAMA neurology·2023

Area of Science:

  • Neuroimmunology
  • Oncology
  • Neurology

Background:

  • Paraneoplastic neurological syndromes (PNS) are rare autoimmune disorders triggered by cancer.
  • The precise immune mechanisms underlying neuronal dysfunction in PNS are not fully understood.

Purpose of the Study:

  • To review recent advances in the aetiology, investigation, and management of PNS.
  • To discuss current controversies and emerging research in the field.

Main Methods:

  • Review of current literature on PNS.
  • Analysis of antibody studies and cellular immunity research.
  • Evaluation of diagnostic tools and treatment outcomes.

Main Results:

  • While anti-glutamate receptor antibodies show pathogenic activity in some PNS cases, the role of antibodies in general remains unclear.

Related Experiment Videos

  • Research increasingly focuses on adaptive cellular immunity, identifying cytotoxic T lymphocytes targeting neuronal antigens.
  • Effective tumor treatment can lead to neurological symptom improvement or stabilization in some patients.

    • Conclusions:

    • Clinical management of PNS has advanced, with improved diagnostics like antibody testing and FDG-PET scans.
    • The specific immune effectors causing neurological damage in most PNS cases require further characterization.
    • Understanding cellular immunity is crucial for future therapeutic strategies in PNS.